News AtriCure, Inc.

Stocks

ATRC

US04963C2098

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-11-06 EST			5-day change	1st Jan Change
58.54 ^USD	-4.47%		-4.42%	+47.98%

11-05	Atricure Insider Sold Shares Worth $546,260, According to a Recent SEC Filing	MT
11-04	Needham Raises Price Target on AtriCure to $70 From $64, Keeps Buy Rating	MT

All News

Mentions Relevance

11-05	Atricure Insider Sold Shares Worth $546,260, According to a Recent SEC Filing	MT
11-04	Needham Raises Price Target on AtriCure to $70 From $64, Keeps Buy Rating	MT
11-04	AtriCure, Inc., Q3 2026 Earnings Call, Nov 03, 2026
11-03	AtriCure Swings to Q3 Adjusted Earnings as Revenue Rises; Shares Drop After Hours	MT
11-03	(ATRC) AtriCure Expects 2026 Adjusted EPS Range $0.40-$0.46	MT
11-03	(ATRC) AtriCure Now Expects 2026 Revenue Range $606M-$610M, vs. FactSet Est of $606.2M	MT
11-03	Earnings Flash (ATRC) AtriCure, Inc. Posts Q3 Adjusted EPS $0.17 per Share, vs. FactSet Est of $-0.06	MT
11-03	Earnings Flash (ATRC) AtriCure, Inc. Reports Q3 Revenue $154.4M, vs. FactSet Est of $151.1M	MT
11-03	AtriCure Reports Third Quarter 2026 Financial Results	BU
11-03	Atricure, Inc. Provides Earnings Guidance for the Full Year 2026	CI
11-03	AtriCure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
10-26	AtriCure to Participate at Upcoming Investor Conferences	BU
10-13	AtriCure to Announce Third Quarter 2026 Financial Results	BU
09-24	Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing	MT
09-21	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 1000	CI
09-20	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 600 Health Care	CI
09-20	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P Composite 1500	CI
09-20	AtriCure, Inc.(NasdaqGM:ATRC) added to S&P 600	CI
09-04	Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing	MT
09-02	Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating	MT
08-26	Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing	MT
08-25	AtriCure to Participate in the 2026 Wells Fargo Health Care Conference	BU
07-30	Atricure Insider Sold Shares Worth $946,000, According to a Recent SEC Filing	MT
07-28	UBS Adjusts Price Target on AtriCure to $50 From $55, Maintains Buy Rating	MT
07-27	Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors	AQ